Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 29 Apr 2022 for 健帆生物, €5,885.
Filing timeline
BuySale何小莲
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
何小莲: trading record in brief
All filings by 何小莲 on record concern 健帆生物, in the capacity of chief executive. Over a trading history stretching from 27 April 2022 to 29 April 2022, the count stands at 2 filings.
The open-market record consists of 2 sales worth €94k, with no purchase.
On 29 April 2022 came the latest disclosure, an open-market sale for €5,885 in 健帆生物. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Companies and markets linked to 何小莲
Open company profiles for insider transactions, fundamentals and analyst consensus when available.